/VICA

VICA Stock - Rafina Innovations Inc.

Q: What is the analyst price target for VICA?

Analyst price target information is not currently available for VICA.

Q: What is VICA's market cap?

Market capitalization information is not currently available for VICA.

Healthcare|Medical - Devices|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

100

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for VICA

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2017

FY2018

FY2019

FY2020

FY2021

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta6.74

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2021	FY2020	FY2019	FY2018	FY2017
Revenue	$3.26M	N/A	$55,521	$412,682	$355,736
Gross Profit	$-168,548	$-46,902	$53,043	$268,314	$225,564
Gross Margin	-5.2%	N/A	95.5%	65.0%	63.4%
Operating Income	$-868,250	$-60,680	$-1,176,740	$-4,236,389	$-2,882,480
Net Income	$-879,207	$-84,978	$-1,197,377	$-5,849,832	$-2,987,426
Net Margin	-26.9%	N/A	-2156.6%	-1417.5%	-839.8%
EPS	$-0.01	$-0.00	$-0.07	$-0.43	$-0.30

Company Overview

Rafina Innovations Inc. engages in the research, development, commercialization, and marketing of medical technologies. It operates through two segments, Clinics and Technology. The company also operates prosthetics and orthotics, and diabetic foot total rehabilitation clinics in Southern Europe, the Middle East, and North Africa. In addition, it is involved in the research, development, and commercialization of medical devices, methods, and products in the fields of prosthetics, orthotics, rehabilitation, bioengineering, mobility, diabetes, diabetic foot, tissue mechanics, ultrasonics, medical signal processing and analysis, medical technology, orthopedics, and robotic surgery; and licensing of its proprietary technologies. The company was formerly known as HCi Viocare and changed its name to Rafina Innovations Inc. in July 2018. Rafina Innovations Inc. was founded in 2007 and is based in Glasgow, the United Kingdom.

Visit Website

Frequently Asked Questions about VICA

What is VICA's current stock price?

Rafina Innovations Inc. (VICA) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for VICA?

No analyst price targets are currently available for this stock.

What sector is Rafina Innovations Inc. in?

Rafina Innovations Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the OTC exchange.

What is VICA's market cap?

Rafina Innovations Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does VICA pay dividends?

No, Rafina Innovations Inc. does not currently pay a dividend to shareholders.